Episode

What's next for GLP-1 weight loss drugs?

Podcast
Beyond Lab Walls | Salk Institute
Published
Jan 26, 2026
Duration seconds
1226
Processing state
not_requested
Canonical source
https://f6581ef4-4950-4497-9ce2-674af8984163.libsyn.com/whats-next-for-glp-1-weight-loss-drugs
Audio
https://traffic.libsyn.com/secure/f6581ef4-4950-4497-9ce2-674af8984163/BLW-GLP1.mp3?dest-id=4348308
JSON
/v1/public/podcasts/beyond-lab-walls-salk-institute-6780063/episodes/what-s-next-for-glp-1-weight-loss-drugs
Markdown
/podcast/beyond-lab-walls-salk-institute-6780063/what-s-next-for-glp-1-weight-loss-drugs.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/beyond-lab-walls-salk-institute-6780063/episodes/what-s-next-for-glp-1-weight-loss-drugs/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/beyond-lab-walls-salk-institute-6780063/what-s-next-for-glp-1-weight-loss-drugs.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Salk scientist Christian Metallo, PhD, weighs in on the pros and cons of GLP-1 drugs and gives us a sneak peek into how metabolism research at Salk could inspire the next generation of obesity and weight management treatments.